BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership62,991 shares
Latest Disclosed Value $ 3,558,374
Fifth Third Bancorp reports 7,695.92% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 62,991 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $3,558,362 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 808 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 7,695.92% during the quarter. The current value of the position is $3,443,088 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 62,991 62,183 7,695.92 3,558 7,312.50 0.0065
2026-02-02 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 808 -584 -41.95 48 -36.00 0.0002
2025-11-07 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,392 -212 -13.22 75 -14.77 0.0002
2025-07-15 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,604 -777 -32.63 88 -47.62 0.0003
2025-04-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,381 1,030 76.24 168 90.91 0.0006
2025-01-21 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,351 165 13.91 89 6.02 0.0003
2024-10-17 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,186 -350 -22.79 83 -34.13 0.0003
2024-07-22 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,536 1,352 734.78 126 687.50 0.0005
2024-04-23 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 184 -41 -18.22 16 -23.81 0.0001
2024-01-19 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 225 -1,759 -88.66 22 -88.00 0.0001
2023-10-31 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,984 1,691 577.13 176 600.00 0.0008
2023-07-26 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 293 52 21.58 25 8.70 0.0001
2023-04-24 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 241 64 36.16 23 27.78 0.0001
2023-01-25 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 177 158 831.58 18 800.00 0.0001
2022-10-25 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19 -238 -92.61 2 -90.48 0.0000
2022-08-04 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 257 238 1,252.63 21 2,000.00 0.0001
2022-04-19 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19 -5 -20.83 1 -50.00 0.0000
2022-02-01 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24 -43 -64.18 2 -60.00 0.0000
2021-10-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67 7 11.67 5 0.00 0.0000
2021-08-06 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 60 -1 -1.64 5 0.00 0.0000
2021-05-07 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 61 -94 -60.65 5 -64.29 0.0000
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 155 -235 -60.26 14 -53.33 0.0001
2020-11-09 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 390 357 1,081.82 30 650.00 0.0002
2020-08-05 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33 -44 -57.14 4 -42.86 0.0000
2020-05-05 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 77 62 413.33 7 600.00 0.0000
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15 -8 -34.78 1 -50.00 0.0000
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23 8 53.33 2 100.00 0.0000
2019-08-07 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15 0 0.00 1 0.00 0.0000
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15 -316 -95.47 1 -96.43 0.0000
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 331 72 27.80 28 12.00 0.0002
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 259 60 30.15 25 31.58 0.0002
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 199 0 0.00 19 18.75 0.0001
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 199 -76 -27.64 16 -36.00 0.0001
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 275 93 51.10 25 47.06 0.0002
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 182 -25 -12.08 17 -10.53 0.0001
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 207 21 11.29 19 18.75 0.0001
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 186 -15 -7.46 16 -5.88 0.0001
2017-02-13 2016-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 201 -312 -60.82 17 -63.83 0.0001
2017-02-09 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 513 0 47 0.0004
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 513 123 31.54 47 56.67 0.0004
2016-08-11 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 390 33 9.24 30 3.45 0.0003
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 357 203 131.82 29 81.25 0.0003
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 154 -115 -42.75 16 -42.86 0.0001
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 269 55 25.70 28 -3.45 0.0003
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 214 161 303.77 29 314.29 0.0003
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 53 -547 -91.17 7 -83.33 0.0001
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 600 0 0.00 42 -2.33 0.0004
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 600 600 43 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.